Clover Biopharmaceuticals

Clover Biopharmaceuticals company information, Employees & Contact Information

Founded in 2007, we are a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world. With integrated research and development, manufacturing, and commercial capabilities as well as strong partnerships with organizations globally, we have developed a diverse pipeline of candidates that have the potential to meaningfully reduce the burden of vaccine-preventable diseases—and to make more diseases preventable. As we focus on delivering vaccines for a healthier world, we remain steadfast in our dedication to both scientific innovation and equitable access. Read our Community Guidelines: https://www.cloverbiopharma.com/community-guidelines.html

Company Details

Employees
160
Founded
-
Address
49f, Park Place, 1598-1601 West Nanjing Road, Jing'an District, Shanghai,200040,china
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Clover Pharmacy.
HQ
Shanghai
Looking for a particular Clover Biopharmaceuticals employee's phone or email?

Clover Biopharmaceuticals Questions

News

CEPI and Clover expand partnership for COVID-19 vaccine to include evaluation as a booster - CEPI

CEPI and Clover expand partnership for COVID-19 vaccine to include evaluation as a booster CEPI

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing - PR Newswire

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing PR Newswire

Clover Appoints Nicholas Jackson, Ph.D., as President - citybiz

Clover Appoints Nicholas Jackson, Ph.D., as President citybiz

CEPI expands partnership with Clover Biopharmaceuticals to rapidly advance development and manufacture of COVID-19 vaccine candidate - CEPI

CEPI expands partnership with Clover Biopharmaceuticals to rapidly advance development and manufacture of COVID-19 vaccine candidate CEPI

Clover Biopharmaceuticals Receives Pharmaceutical Manufacturing Permit from Zhejiang Medical Products Administration to Produce COVID-19 Vaccine - PR Newswire

Clover Biopharmaceuticals Receives Pharmaceutical Manufacturing Permit from Zhejiang Medical Products Administration to Produce COVID-19 Vaccine PR Newswire

Clover Biopharma launches quadrivalent influenza vaccine in Mainland China - BioSpectrum Asia

Clover Biopharma launches quadrivalent influenza vaccine in Mainland China BioSpectrum Asia

CEPI extends partnership with Clover to fund COVID-19 vaccine candidate through global Phase 2/3 study to licensure - CEPI

CEPI extends partnership with Clover to fund COVID-19 vaccine candidate through global Phase 2/3 study to licensure CEPI

Clover's COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest - PR Newswire

Clover's COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest PR Newswire

Top Clover Biopharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant